Keywords
MedicineImpaired fasting glucoseInsulin glargineInternal medicineGlycated hemoglobinDiabetes mellitusGlycemicImpaired glucose tolerancePlaceboInsulinType 2 diabetesHazard ratioEndocrinologyGastroenterologyConfidence interval
Affiliated Institutions
Related Publications
UKPDS 28: A Randomized Trial of Efficacy of Early Addition of Metformin in Sulfonylurea-Treated Type 2 Diabetes
OBJECTIVE To assess the efficacy over 3 years of the addition of metformin to maximum sulfonylurea therapy in type 2 diabetes. RESEARCH DESIGN AND METHODS This multicenter rando...
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
When used to target normal fasting plasma glucose levels for more than 6 years, insulin glargine had a neutral effect on cardiovascular outcomes and cancers. Although it reduced...
Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.
We have assessed the mechanisms involved in the pathogenesis of the insulin resistance associated with impaired glucose tolerance and Type II diabetes mellitus by exploring, by ...
Glucose Potassium Insulin Infusions in the Treatment of Acute Stroke Patients With Mild to Moderate Hyperglycemia
Background and Purpose —Hyperglycemia following acute stroke is strongly associated with subsequent mortality and impaired neurological recovery, but it is unknown whether maint...
Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum
The International Diabetes Federation estimates that 415 million adults worldwide now have diabetes and 318 million have impaired glucose tolerance. These numbers are expected t...
Publication Info
- Year
- 2007
- Type
- article
- Volume
- 155
- Issue
- 1
- Pages
- 26.e1-26.e13
- Citations
- 204
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
204
OpenAlex
Cite This
The ORIGIN Trial Investigators
(2007).
Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).
American Heart Journal
, 155
(1)
, 26.e1-26.e13.
https://doi.org/10.1016/j.ahj.2007.09.009
Identifiers
- DOI
- 10.1016/j.ahj.2007.09.009